학술논문
299PThe prevalence of PIK3CA mutations in HR+/HER2– metastatic breast cancer (BELLE2, BELLE3 and BOLERO2 clinical trials).
Document Type
Article
Author
Source
Subject
*METASTATIC breast cancer
*GENETIC mutation
*HORMONE receptors
*
*
Language
ISSN
0923-7534